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Abstract
The Anelloviridae family consists of non-enveloped, circular, single-stranded DNA viruses. Three genera of anellovirus are
known to infect humans, named TTV, TTMDV, and TTMV. Although anelloviruses were initially thought to cause non-A-G
viral hepatitis, continued research has shown no definitive associations between anellovirus and human disease to date.
Using high-throughput sequencing, we investigated the association between anelloviruses and fever in pediatric patients
2–36 months of age. We determined that although anelloviruses were present in a large number of specimens from both
febrile and afebrile patients, they were more prevalent in the plasma and nasopharyngeal (NP) specimens of febrile patients
compared to afebrile controls. Using PCR to detect each of the three species of anellovirus that infect humans, we found
that anellovirus species TTV and TTMDV were more prevalent in the plasma and NP specimens of febrile patients compared
to afebrile controls. This was not the case for species TTMV which was found in similar percentages of febrile and afebrile
patient specimens. Analysis of patient age showed that the percentage of plasma and NP specimens containing anellovirus
increased with age until patients were 19–24 months of age, after which the percentage of anellovirus positive patient
specimens dropped. This trend was striking for TTV and TTMDV and very modest for TTMV in both plasma and NP
specimens. Finally, as the temperature of febrile patients increased, so too did the frequency of TTV and TTMDV detection.
Again, TTMV was equally present in both febrile and afebrile patient specimens. Taken together these data indicate that the
human anellovirus species TTV and TTMDV are associated with fever in children, while the highly related human anellovirus
TTMV has no association with fever.
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Introduction
In 1997 the novel virus Torque Teno Virus (TTV) was isolated
from a Japanese patient who developed post-transfusion non-A-G
hepatitis [1]. Further analysis classified TTV as a non-enveloped,
single-stranded DNA virus with a circular, negative-sense genome
[1,2]. In 2000, researchers using TTV-specific PCR primers
amplified a smaller virus which was subsequently named Torque
Teno-like Mini Virus (TTMV) [3]. A third virus with a genomic
size in between that of TTV and TTMV was discovered in 2007
and subsequently named Torque Teno-like Midi Virus (TTMDV)
[4]. Recent changes in nomenclature have classified the three
anelloviruses able to infect humans into Alphatorquevirus (TTV),
Betatorquevirus (TTMV), and Gammatorquevirus (TTMDV)
Genera of the Anelloviridae family of viruses [5]. Despite the
early association with hepatitis, further studies have ruled out
anelloviruses as a cause of clinically significant liver disease [6,7,8].
Researchers have studied anelloviruses in the context of many
diseases. Associations between anellovirus and acute respiratory
disease have been described, but it is difficult to determine
causation vs. correlation due to the ubiquitous nature of
anelloviruses [9,10,11]. To date anelloviruses are still considered
‘‘orphan’’ viruses waiting to be linked to human disease [12].
As indicated by their names, the human anelloviruses differ in
genome size ranging from 3.8–3.9 kb for TTV, 3.2 kb for
TTMDV, and 2.8–2.9 kb for TTMV. A characteristic feature of
anelloviruses is the extreme diversity found both within and
between anellovirus species; they can exhibit as much as 33%–
50% divergence at the nucleotide level
[3,13,14,15,16,17,18,19,20]. Despite the nucleotide sequence
diversity, anelloviruses share conserved genomic organization,
transcriptional profiles, a non-coding GC rich region, and
sequence motifs resulting in shared virion structure and gene
functions [3,21,22,23,24,25,26,27].
Anellovirus infections are highly prevalent in the general
population. A study in Japan found that 75–100% of patients
tested were infected with at least one of the three human
anelloviruses, and many were infected with multiple species [28].
Anelloviruses can infect young children, with the earliest
documented infections occurring within the first months of life
[29]. These viruses have been found in nearly every body site,
fluid, and tissue tested including blood plasma, serum, peripheral
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blood mononuclear cells (PBMCs), nasopharyngeal aspirates, bone
marrow, saliva, breast milk, feces, as well as various tissues
including thyroid gland, lymph node, lung, liver, spleen, pancreas,
and kidney [2,25,30,31,32,33,34,35,36]. The replication dynamics
of anelloviruses are virtually unknown because of the inability to
propagate these viruses in culture. Positive-strand TTV DNA,
indicative of local viral replication, has been described in
hepatocytes, bone marrow cells, and circulating PBMCs
[37,38,39]. Another report proposes that anelloviruses replicate
exclusively in tissue because the viral load can be up to 300 times
higher than that detected in plasma. This explanation is
complicated due to the highly variable viral loads detected in
tissue and plasma from patient to patient. More research is
necessary to determine the exact site of anellovirus replication
[36].
Antibody detection of anellovirus infection has been reported by
several labs, but usage of these assays has not spread beyond the
originating laboratories. The largest study by Ott et al.–consisting
of 70 adults and children–identified TTV antibodies in 98.6
percent of patients tested. TTV-IgM antibodies were negative for
all of the patients suggesting that the TTV infections were not
newly acquired. TTV DNA was detected in 76.1% of the sera,
indicating active infection [40]. High viral titers found in patient
specimens suggest that anelloviruses cause chronic, persistent
infection for life.
Anelloviruses are spread primarily through fecal-oral trans-
mission, although mother-child and respiratory tract transmissions
have also been reported [9]; [2,41]. There are conflicting reports
regarding the presence of TTV in cord blood specimens [42,43].
Analysis of TTV DNA from infected mothers and infants showed
that the strains were highly related in only a small number of cases,
suggesting that vertical transmission is responsible for a very small
amount of anellovirus infections [44].
Fever is one of the most common reasons children go to the
emergency department, resulting in over 5.6 million visits in 2007
[45]. In the past, bacteremia was a common source of fever in
children. The recent development of Haemophilus influenzae and
Streptococcus pneumoniae vaccines have reduced the frequency of
serious bacterial infections in children, making bacteremia an
uncommon cause of fever. Localized bacterial infection, such as
urinary tract infections, cause 5–10% of fevers in children, but
there remains a large percentage of febrile children in which the
source of their fever is never identified. Viral illnesses are believed
to cause the majority of cases of fever without a source and result
in significant morbidity and mortality especially in young children
[46]. Viruses such as human herpes virus 6, Epstein–Barr virus,
and adenovirus are known to cause fever in children [47,48,49],
and advances in molecular diagnostic techniques have led to the
discovery of unknown or underappreciated viruses associated with
human disease. In a study of fever in children, we commonly
found anelloviruses in our specimens based on high-throughput
sequencing [50]. Therefore we were interested in further in-
vestigating the association between anelloviruses and fever in
children.
Results
Anelloviruses were more Prevalent in Febrile Patient
Specimens by High-throughput Sequencing
To identify viruses associated with fever in children we
performed high-throughput sequencing on 52 plasma and
151 NP specimens using the Illumina GA IIx platform. These
specimens were obtained from children 2–36 months of age
presenting to the Emergency Department at Saint Louis
Children’s Hospital with a temperature greater than or equal to
38 degrees Celsius. Afebrile controls consisted of children in the
same age range who were having ambulatory surgery for non-
acute conditions. High-throughput sequencing was chosen be-
cause it is an unbiased approach that can lead to identification of
known viruses and has the possibility of uncovering novel viruses
as well [50]. After sequencing we found that many of the
specimens from our patient cohort contained anellovirus DNA.
Anellovirus DNA was present in plasma and NP specimens from
both febrile and afebrile patients. In each case further analysis
showed that a higher percentage of specimens from febrile patients
contained anellovirus DNA compared to specimens from afebrile
patients (plasma, p = 0.034; NP p= 0.002) (Fig. 1A–B). Patient-
level analysis showed that patients with fever were more likely to
have anelloviruses detected in one or both samples than were
afebrile patients, although the data did not reach statistical
significance (Fig. 1C). Overall these data suggest an association
between children being febrile and having anellovirus DNA
detectable in their plasma and NP specimens.
Although high-throughput sequencing is not precisely quanti-
tative, we hypothesized that a larger number of anellovirus reads
could be suggestive of a higher viral load. In order to compare
samples, the total number of reads was normalized to 3 million
reads per specimen. Plasma specimens from afebrile patients
contained a similar number of anellovirus sequence reads
compared to those from febrile patients, with a median of 10.2
and 15.6 reads, respectively (Fig. 1D). The median number of
anellovirus sequence reads was also similar between afebrile and
febrile NP specimens at 2.9 and 1.7 reads, respectively (Fig. 1E).
The range of anellovirus sequence reads was higher in plasma
specimens, ranging from one to nearly five thousand reads per
specimen. Anellovirus-positive NP specimens all had fifty or fewer
sequence reads per specimen. These data suggest that the
anellovirus viral load is likely similar between febrile and afebrile
patients and that the amount of anellovirus present in plasma
specimens varies widely between individuals.
To determine if anellovirus DNA was more likely to be found in
the plasma or NP specimens of our patient cohort we analyzed 48
patients who had high-throughput sequencing performed on both
their plasma and NP specimens. Anellovirus DNA was detected in
the plasma and NP specimens of 22 patients and detected in
neither specimen for 6 patients (p = 0.0001) (Fig. 1F). Twenty
patients had anellovirus sequences detected in their plasma but not
NP specimens. These data suggest that the anellovirus viral load is
below the level of detection in the upper respiratory tract or that
many children develop systemic anellovirus infection that involves
the blood but not the upper respiratory tract.
Human Anellovirus Species TTV and TTMDV were more
Prevalent in Febrile Patient Specimens by PCR
After making our initial observations using high-throughput
sequence data, we expanded our analysis to a larger set of
specimens using PCR assays designed to detect TTV, TTMDV,
and TTMV. We hypothesized that specific anellovirus species
were associated with fever in children while other species may
have no association. To test our hypothesis we developed
conventional PCR assays to detect TTV, TTMDV, and TTMV
using primers validated by Ninomiya et al. [29]. PCR for TTV,
TTMDV, and TTMV was performed on 219, 213, 216 plasma
specimens, respectively. All three PCR assays were also performed
on 247 NP specimens. Patient-level analysis was performed to
evaluate individuals with anellovirus DNA in their plasma and/or
NP specimens. In agreement with high-throughput sequencing,
anellovirus DNA was detected in a high percentage of specimens
Anellovirus in Pediatric Patients with Fever
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from both febrile and afebrile patients. Analysis of the two
specimen types for specific anellovirus species showed that TTV
DNA was present in a higher percentage of NP specimens from
febrile patients compared to afebrile controls (p = 0.0182); results
were similar, but not statistically significant, for plasma specimens
(Fig. 2A). The same trend was true for TTMDV, but to a lesser
extent than TTV (Fig. 2B). These results indicate an association
between infection with TTV and possibly TTMDV and fever in
children. In contrast, TTMV DNA was found in similar
percentages of febrile and afebrile patient specimens indicating
that TTMV infection is not associated with fever in children
(Fig. 2C). Patient level analysis was performed in which patients
with TTV, TTMDV, or TTMV DNA in their plasma, NP, or
both specimens were considered positive. This analysis showed
that approximately 80% of all patients were positive for anellovirus
regardless of their febrile or afebrile status, and that TTV was
present in a higher percentage of febrile patients compared to
afebrile controls (TTV, p= 0.0026). TTMDV followed the same
trend as TTV, but the difference between febrile patients and
afebrile controls did not reach statistical significance. The majority
of patients in our cohort were positive for TTV, TTMDV, or
TTMV DNA in both their plasma and NP specimens (Fig. 2D).
The next largest group consisted of patients without TTV,
TTMDV, or TTMV DNA detected in either their plasma or NP
specimens. Depending on the species, only 13–19 percent of
patients were positive for TTV, TTMDV, or TTMV DNA in only
one specimen. The frequency was equally split between patients
positive in only their plasma or NP specimen.
Our data show that TTV and TTMDV, but not TTMV, are
associated with fever in children. These data indicate that the
three human anellovirus species are not interchangeable, and
suggest that TTV, TTMDV, and TTMV play different roles in
pathogenesis and disease.
Patient Specimens Contain Multiple Human Anellovirus
Species
To determine if patients in our cohort were co-infected with
multiple anellovirus species, we analyzed our PCR data for the
simultaneous presence of TTV, TTMDV, and TTMV DNA in
plasma and NP specimens. We found that the majority of
specimens were positive for more than one human anellovirus
species (Fig. 3A–B). This was true of specimens from both febrile
and afebrile patients. The largest group consisted of specimens
containing all three anellovirus species while less than ten percent
of specimens were negative for all three human anelloviruses.
To investigate whether anelloviruses formed synergistic relation-
ships with other known viral pathogens we analyzed the presence
of anelloviruses with respect to 20 other common viruses that were
previously tested for in the same samples (ref Colvin). (data not
shown). Our analysis showed that specimens with anelloviruses
were not more likely to be positive for other viruses than specimens
without anelloviruses. This was true for the individual viruses we
tested, as well as for viruses as a whole. Thus, we did not find any
associations between TTV, TTMDV, or TTMV and other viral
pathogens, suggesting that anelloviruses do not have synergistic
interactions with other common viral pathogens.
Associations with Age, Gender, and Race
To investigate the relationship between anelloviruses and
patient demographics we used our PCR data to assess the
prevalence of anellovirus in relation to patient age, race, and
Figure 1. Anellovirus DNA was more prevalent in specimens from febrile children by high-throughput sequencing. A–B. High-
throughput sequencing analysis of plasma (A) and NP (B) specimens showed that a higher percentage of specimens from febrile children contained
anellovirus DNA compared to specimens from afebrile children (plasma, p = 0.034; NP, p = 0.002). C. The trend was the same, but not statistically
significant at the patient level of analysis. D–E. Afebrile and febrile patients had a similar median number of anellovirus sequence reads in their
plasma (10.2 vs. 15.6) (D) and NP (2.9 vs. 1.7) (E) specimens. F. Anellovirus sequences detected by high-throughput sequencing were more prevalent
in plasma compared to NP specimens (p,0.0001; Chi-squared test).
doi:10.1371/journal.pone.0050937.g001
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gender. Patients infected with TTV and TTMDV had a higher
median age than uninfected patients (median age TTV pos = 12
months vs. TTV neg= 8 months (p = 0.015 by Kolmogorov-
Smirnov test); TTMDV pos= 12 months vs. TTMDV neg= 6
months (p = 0.002, Kolmogorov-Smirnov test); data not shown).
Children infected with the anellovirus species TTMV had
comparable mean and median ages to children who were
uninfected (TTMV pos = 11 months vs. TTMV neg= 12 months;
data not shown). It is logical that patients are exposed to more
viruses as they age, but the similar median age of TTMV positive
and negative children demonstrates that the age effect we see with
TTV and TTMDV is not due solely to patients acquiring common
Figure 2. PCR analysis showed that DNA from human anellovirus species TTV and TTMDV, but not TTMV, were more prevalent in
febrile patient specimens compared to afebrile controls. A–C. PCR identified TTV (A) and TTMDV (B) in a higher percentage of febrile patients
compared to afebrile controls while TTMV (C) was present in equivalent percentages (plasma TTV, p = 0.0567; NP TTV, p = 0.0182; patient TTV,
p = 0.0026). D. The majority of patients were either positive or negative for TTV, TTMDV, and TTMV DNA in both their plasma and NP specimens. P-
values determined by chi-squared test.
doi:10.1371/journal.pone.0050937.g002
Figure 3. Many patient specimens contained DNA from multiple human anellovirus species. A–B. Patient plasma (A) and NP (B)
specimens were assayed for TTV, TTMDV, and TTV DNA by PCR and the percentage of specimens with 3, 2, 1, or no anellovirus species were
determined.
doi:10.1371/journal.pone.0050937.g003
Anellovirus in Pediatric Patients with Fever
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viruses as they age. To investigate the association between
anelloviruses and age more closely we combined patients into
groups consisting of six month age blocks. We then analyzed the
percentage of children in each age group who were positive for
TTV, TTMDV, and TTMV DNA in plasma or NP specimen.
The youngest group, consisting of children 2–6 months of age, had
relatively low percentages of TTV and TTMDV DNA in their
plasma and NP specimens (Fig. 4A–D). The percentage of
anellovirus positive specimens climbed with increasing age,
peaking at 19–24 months, and then declined from 25–36 months.
A very modest rise and fall was seen in TTMV-positive plasma
and NP specimens (Fig. 4E–F). We expected to find a lower
frequency of anellovirus infections in younger patients, but were
surprised to see the frequency of anellovirus peak and then drop
after 24 months of age. These data suggest that a subset of patients
may be able to clear anelloviruses from their bodies or suppress
anellovirus replication to below the level of detection for our PCR
assay.
Another parameter we investigated was the race of patients
infected with anelloviruses. We found that DNA from TTV and
TTMDV, but not TTMV, was more prevalent in African-
American patients compared to Caucasian patients (Fig. 4G). Our
analysis was complicated by the fact that more African-American
patients were in our febrile group compared to our afebrile control
group due to the usage patterns of the Emergency Department
and Ambulatory Surgery. Conversely, Caucasian patients were
over represented in our afebrile control group. In multivariate
logistic models, race was not significantly assoicated with the
presence of anelloviruses after adjusting for the febrile status.
Patients classified as Asian, Hispanic, and other were present in
such small numbers that they were excluded from this analysis. We
also analyzed the presence of anelloviruses in male and female
patients, and found no significant differences according to gender
(Fig. 4H).
Anellovirus Infection Correlates with Elevated
Temperatures in Children
The maximum temperature of all patients in our cohort was
recorded and any patient with a temperature of 38uC or higher
was considered febrile for the purposes of our study. Children were
then grouped by one-half degree Celsius increments in their
maximum temperatures, and we determined the percent of
children in each group who were positive for TTV, TTMDV,
or TTMV DNA. There was a striking correlation between the
height of the maximum temperature and the frequency of TTV
and TTMDV infection (Fig. 5A–B). Fewer than half of children
with maximum temperatures of 38–38.5uC were positive for TTV
or TTMDV DNA. In contrast, nearly 100% of children with
a maximum temperature of 40uC or higher were infected with
TTV or TTMDV. The presence of TTMV DNA did not have
a similar correlation with maximum temperature as TTV and
TTMDV (Fig. 5 C). Regardless of the height of the maximum
temperature, 80–90% of febrile children were infected with
TTMV.
Discussion
The focus of our research study was to investigate the
association of individual anellovirus species with febrile illness in
young children. Interestingly, we found that TTV, TTMDV, and
TTMV do not exhibit the same biological behavior. A paper by
Rocchi et al. speculated that the sequence diversity found within
and between anellovirus species may affect the immune response
to the virus, resulting in different effects on the body during
infection [51]. In our study TTV and TTMDV were associated
with febrile illness. In contrast, TTMV was equally common in
febrile and afebrile children.
Early research on anelloviruses drastically underreported their
prevalence in patient specimens. The Anellovirdae family of viruses
is extremely diverse. They have few conserved regions between
species and also within species, making it difficult to design PCR
primers that amplify all anelloviruses that might be present in
patient specimens [52,53]. Continued research has revealed a high
level of diversity of anellovirus at the nucleotide level, and
appreciation of this diversity has led to higher frequency of
detection of anelloviruses in patient specimens, including healthy
controls [12,29]. We used conventional end point PCR assays to
detect TTV, TTMDV, and TTMV. To ensure that our PCR
assays were achieving maximum broad range detection of
individual anellovirus species (TTV, TTMDV, and TTMV) as
possible, we used primers that were homologous to sequences
within the GC rich region upstream of the OFR1 transcription
start site. This is the most conserved region in the Anellovirdae
family of viruses but also provides conserved sequences that are
unique for each species of viruses. We used multiple forward and
reverse primers to maximize the range of detection within each
anellovirus species. Synthetic oligonucleotides representing two
diverse sequences within each anellovirus species were used as
positive controls to ensure that our PCR primers and conditions
were suitable for amplification of diverse anellovirus sequences.
In our study we investigated various patient demographic
parameters to determine whether they correlated with the
presence of anelloviruses in our patient cohort. We were also
interested in racial differences in virus distribution. Using
univariate analyses, African-American subjects had a significantly
higher prevalence of anelloviruses. However, in our population
race was highly correlated with febrile status–57% of febrile
children were African-American and 43% were Caucasian, while
15% of afebrile controls were African-American and 85% were
Caucasian. In multivariate logistic models race was not significant
after adjusting for the febrile status. Since race and fever status
were so highly collinear, we assessed the effect of race in analyses
stratified by maximum temperature. In a subsample of afebrile
subjects African-American subjects had significantly higher
presence of TTV virus than Caucasian subjects (OR: 4.9, 1.01–
23.35, p = 0.048). No racial differences were found in febrile
patients for TTV or for either febrile or afebrile for TTMDV.
We also investigated the age of patients infected with
anellovirus. Based on the concept that anelloviruses cause
persistent infection, we hypothesized that older children would
be more likely than younger children to be infected due to a longer
exposure time to anellovirus-positive family members and other
children. We found that children with TTV and TTMDV DNA
detected in their plasma or NP specimens were older than
uninfected children. This was not the case for TTMV as children
in which TTMV DNA was detected were no different in age from
those in which TTMV DNA was not detected. After grouping our
patient cohort into 6 month age blocks we found that the
percentage of anellovirus-positive specimens rose as age increased
and peaked at 19–24 months, after which the percent of positive
specimens declined. The trend was striking in the TTV and
TTMDV-positive plasma and NP specimens and modest in the
TTMV-positive plasma and NP specimens. This was a surprising
finding because research in the anellovirus field has shown that
they are chronic, replicating viruses, with no evidence that they are
cleared from body or enter into a latent life cycle phase. We saw
the same trend in plasma and NP specimens tested for all three
human anellovirus species suggests that the finding is real and that
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further analysis is needed to explain this phenomenon. In our
study, each patient was sampled only once; however, longitudinal
studies in which the onset of anellovirus infection and the viral
load could be assessed would allow us to address the question of
anellovirus persistence.
Our study showed that DNA from anellovirus species TTV and
TTMDV, but not TTMV, were related to fever in young children.
Most strikingly we found that the higher the temperature, the
larger the percentage of patients that were positive for TTV and
TTMDV. Although the relationship is clear, the mechanism by
which this happens is unknown. TTV and TTMDV could be
causing fevers in children, but we believe it is more likely that fever
brought on by other means is creating a permissive environment
for anellovirus replication or decreasing the clearance of the
viruses. The combination of an inflammatory environment and
a weakened immune system could alter the replication and
degradation dynamics affecting infection, proliferation, and
stability of TTV and TTMDV. To address this question one
would need to follow a cohort of patients over time using
a quantitative assay to measure viral titers of TTV and TTMDV.
This type of experimentation would allow one to study the effect of
a patient’s first anellovirus infection as well as anellovirus
replication dynamics as patients undergo various other febrile
illnesses. It would also be interesting to follow anellovirus titers
before and after patients have been placed on immunosuppressant
drug regimens to study the role of the immune system in
anellovirus replication.
In conclusion, our study investigated the interplay between
anelloviruses and fever. By high-throughput sequencing we found
more anellovirus DNA in the plasma and NP specimens of febrile
patients compared to afebrile controls. PCR detection of each
anellovirus species showed that TTV and TTMDV, but not
TTMV, were more prevalent in febrile patient specimens
compared to afebrile controls. Finally, as the temperature of
febrile patients increased, so too did the frequency of detection of
DNA from TTV and TTMDV. Overall these data argue that the
anelloviruses TTV and TTMDV are associated with fever in
children.
Materials and Methods
Patient Population
Febrile children age 2–36 months were recruited from the
Emergency Department and afebrile controls were recruited from
the Ambulatory Surgery Department at St. Louis Children’s
Hospital. Febrile children consisted of children with a temperature
greater than 38uC without an apparent source, who were having
blood obtained for a complete blood count and/or a blood culture
for clinical management. Children with clinical syndromes
suggestive of viral respiratory infection, such as bronchiolitis, were
not included. The elevated temperature was documented either in
the Emergency Department or by a health care provider within 24
hours before the Emergency Department evaluation. Children
were excluded if they had an underlying condition that
predisposed them to infection, including cancer, immune de-
ficiency, immunosuppressive therapy, cystic fibrosis, sickle-cell
disease, or presence of an indwelling venous catheter. Children
with a positive rapid test for influenza also excluded. The afebrile
control group consisted of well children 2–36 months of age
having outpatient surgery who had been afebrile for at least 7 days
prior to surgery. Enrollment Children with fever were enrolled
from mid-February, 2007 through mid-February, 2010. Afebrile
control children were enrolled during a 12-month period starting
in mid-February 2009. Children were enrolled by study personnel
who obtained health information from each child’s caregiver,
Figure 4. Anellovirus association with patient age, race, and gender. A–F. Children in whom anellovirus DNA was detected were older than
children in whom anellovirus DNAS was not detected. Patients were broken down by age into 6 month age groups and analyzed for the presence of
DNA from TTV (A–B), TTMDV (C–D), or TTMV (E–F) in patient plasma (A, C, E) or NP (B, D, F) specimens. G. Other demographic analysis showed that
anellovirus species TTV and TTMDV were more prevalent in patient specimens from African-Americans than Caucasians, but using multivariate
logistic models the race effect was not significant after adjusting for the febrile status. H. There was no correlation between anellovirus positivity and
patient gender.
doi:10.1371/journal.pone.0050937.g004
Figure 5. Detection of anellovirus DNA correlates with increasingly elevated temperatures in children. A–B. The percent of patients
infected with detectable TTV (A) and TTMDV (B) rises as patient’s temperature increases. C. The percentage of patients with TTMV DNA detected is
independent of temperature.
doi:10.1371/journal.pone.0050937.g005
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including past history and recent symptoms that might indicate the
presence of an acute infection [54].
Patient Specimens
Plasma and nasopharyngeal swabs were obtained from febrile
and afebrile patients and analyzed for the presence of anellovirus
DNA by high-throughput sequencing and PCR. No patient had
more than one specimen from either body site. The decision to
obtain blood and nasopharyngeal specimens was made by
Emergency Department physicians as part of their standard care
and was not a part of this study.
Ethics Statement
This study was initially approved by the Washington University
Human Research Protection Office and undergoes yearly review.
Written informed consent was obtained from appropriate care-
givers.
High-throughput Sequencing
52 plasma and 151 NP specimens underwent high-throughput
sequencing using the Illumina GA IIx platform to determine the
presence or absence of anellovirus DNA in plasma and NP patient
specimens. Illumina deep sequencing produced read lengths of
100 bp each, and a mean of 4.7 million reads per specimen. To
achieve consistent comparisons between groups, the number of
reads was scaled to three million reads per specimen. The details
of the sequence analysis along with the mean, range, and median
number of reads for this data set can be found in figures S1 and S5
of the manuscript published by Wylie et al. in PLoS ONE (2012)
[50].
PCR Assays
Plasma and NP specimens were analyzed for the presence or
absence of TTV, TTMDV, and TTMV DNA by conventional
PCR. We tested 247 NP specimens for all three human
anelloviruses. Of the plasma specimens, we tested 219, 213, and
216 for TTV, TTMDV, and TTMV, respectively, due to limited
amounts of specimen for some patients. Individual PCR reactions
were developed for each of the three human anelloviruses.
Conditions for our TTV specific PCR assay included an initial
denaturation phase of 2 min. at 94uC followed by 40 cycles of
amplification (94uC for 30 sec, 55uC for 30 sec, 72uC for 30 sec),
and an extension phase of 7 min. at 72uC. TTMDV conditions
were similar with exception of 45 cycles of amplification and an
annealing temperature of 60uC. TTMV required a hemi-nested
PCR. The first round required an annealing temperature of 60uC
and 25 cycles of amplification. The second round required an
annealing temperature of 55uC and 25 cycles of amplification.
Two ml of extracted nucleic acid from our clinical specimen were
amplified by PCR using multiple forward and reverse primers
adapted from Ninomiya et al. [29]: TTV (RGTGRCGAATG-
GYWGAGTTT, ACWKMCGAATGGCTGAGTTT,
CCCCTTGACTBCGGTGTGTAA); TTMDV
(GCCCGARTTGCCCCTAGACC, SGABCGAGCGCAGC-
GAGGAG); TTMV round one (RGTGRCGAATGGYW-
GAGTTT, ACWKMCGAATGGCTGAGTTT,
CCCKWGCCCGARTTGCCCCT, AYCTWGCCC-
GAATTGCCCCT); TTMV round two (TTTATGCYGCYA-
GACGRAGA, TTTAYCMYGCCAGACGGAGA,
TTTATGCCGCCAGACGRAGG, CTCACC-
TYSGGCWCCCGCCC). Two positive controls from the GC
rich region upstream of ORF2, ranging in length from 72–112
base pairs, and consisting of diverse sequences were synthesized for
each anellovirus species to ensure our primers were amplifying
diversity within each species. The limit of detection was,200 viral
copies/ml for all three PCR assays.
Statistics
Statistical significance was determined by Fisher’s exact test
(Fig. 1A–1C), Kolmogorov-Smirnov test (1D–E), McNemar’s test
(1F), and chi-squared (Fig. 2A–C). Multivariate logistic analysis
was performed to determine confounding factors within our data
set, adjusting for age, gender, and race (Fig. 4). Kolmogorov-
Smirnov test was used to compare median age of patients infected
with TTV, TTMDV, and TTMV (data not shown). Trends
testing was performed on data from figure 5, but it did not reach
statistical significance.
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